Sign Arrangement Made Easy

Sign arrangement

hello penny pinchers my name is dahan and welcome back to your number one place for all your investing needs in today's video we're going to be looking at the five top biotech penny stocks to watch for this week we're going to go ahead and dive in and check them all out so the first biotech penny stock we're going to be taking a look at is going to be mankind corporation now this one was pushing up by around 8 on thursday january 21st mankind this game comes to heels of around 106 percent move over the past six month period so with all this momentum what does mnkd do while mankind is a biopharmaceutical company focused on the production of treatment of diabetes and pulmonary conditions this includes its flagship product known as afroza which is an inhalable form of insulin additionally the company is in a licensing agreement with the united therapeutics corp to develop a dry version of the drug theroprostino afrezza currently stands as the company's first fda approved drug and is currently commercialized around the us however mankind has also begun advancing other pipeline treatments last month the company announced that it had entered into a co-promotion deal with a vertica pharma regarding the oral solution of thai quiddity this is a drug used in the treatment of various thyroid conditions that can act as a replacement therapy michael castagna ceo of mankind stated that we are excited to co-promote dyquidite with uh vertica pharma this arrangement allows us to strengthen our relationship with with our current customers expand into pediatric endocrinology and leverage the talent and capabilities of our sales force and reimbursement support system so this one ticker symbol mnkd right there this one was up about three point eight percent at the close on friday and kd is currently trading at three dollars 54 cents we can see here that at pre-ronal levels it was trading around one dollar last year so it's went up about 200 percent since then we can see that volume is you know usually around the one to three million range but we can see right here during the end of the summer and beginning of last fall this stock started to gain some momentum and volume started to push up as well as the price so right here actually towards around the november uh time period we were trading around five to ten million shares every single day and the stock went from that two dollar range all the way up here to highs about three dollars so we made about a fifty percent gain right there in a matter of a few weeks in november then we saw another pop you know we saw a little bit of a pullback then we saw another pop from this two dollar ninety cents area to highs here about four dollars and twenty cents so we saw about a dollar and twenty a dollar and thirty cent pop with volume hitting here about 14 million shares even 60 million shares now we're looking at this pullback a little bit we're consolidating around this three dollar range so we're bouncing off of this 3.20 cents to 3.50 cents area if we can break through this 3.50 area where we're at right now get to that four dollar resistance we can continue to go higher and make new 52 week high so that's we're going to be looking forward to in the upcoming weeks is for volume to continue to push up and for this price action to continue as always guys i appreciate each and every one of you viewing my videos so go ahead and smash that like button let's aim for 500 plus likes on this video in the first 24 hours of it being up we're almost at 16 000 subscribers so go ahead and subscribe to the channel turn on that bell notification so you get notified every time i make a new video also guys if you guys want to sign up for weibo get your four free stocks right there we have two free stocks but now they've updated to four free stocks so you get four free stocks when you sign up with webo right now also guys leave a comment below what penny stocks are you trading right now what penny stocks are you making gains on leave a comment below coming in at the number two spot the second biotech penny stock for this week is going to be sir core inc so this one since november shares of cerc stock are up around 50 percent interestingly enough sir core is currently working on two monoclonal antibodies that may be able to treat the rona as well as a chronic disease this these treatments known as the circ-002 and circ.007 utilize the cytokine tnfsf-14 receptor to produce an optimal immune response additionally the company is developing a drug known as the circ dash007 that could be used to treat adult onset stills disease and myeloma as a biotech company working on a ronald treatment circ stock sees more volatility than other penny stocks but its work on a treatment disk pandemic also could make it a penny stock to watch the company recently announced that it is engaging in a fundraising plan to offer around 14 million shares of common stock the announcement from january 20th revises the original deal adding roughly 4.3 million in proceeds this brings the gross value of the offering to 40.7 million fundraising opportunities like these are quite common in the biotech industry this is because they allow companies to access capital on a needed basis whether or not this will result in shared dilution remains to be seen so this one is going to be ticker symbol cerc like we said right there currently trading at three dollars fifty cents it was up about thirteen point two seven percent as of the close on friday now down here now they changed this look on here so we have the short term midterm long term you know very very bullish right there the performance outlook is up up so if you're looking right here on the chart like we said it was up on friday and if we take a look here on the one-year chart this stock has been bouncing up and down in this pattern so it keeps hitting the support level around this two dollar level and the resistance level around three dollars so it's bouncing between the two and three dollar levels as we can see and it's continuously bounced off of that supported two dollars and now it's at that three dollar resistance level we see volume is picking up we're trading around three million two million even one million shares daily so right now we're at that resistance level we're going to be looking for this one to continue this volume up hopefully some more positive news and some more volume push this one up if we can break through this through three dollar resistance we have all the way until three dollars 50 cents before we hit the next resistance level we have to make it through and break through that 3.50 resistance without bouncing back to that support level at the two dollar range so if we can break through that 3.50 level this one can definitely continue to make higher moves and go all the way up to about four dollars before hitting the next resistance level that we're gonna be looking out for so this is one definitely keep on your watch list for the next few weeks the third biotech penny stock on our list going to be evo evofan biosciences inc so this one its focus is on the women's health and reproductive health industry which includes various compounds flagship product vexi is a hormone-free substance that can prevent pregnancy additionally the company is in a phase 3 clinical trial for the compounds known as the evo 100 or evoguard this drug can treat and prevent chlamydia and gonorrhea infections in women who need it while this market may seem specialized there's quite a lot of opportunity for companies like evofem additionally evofem has several drugs in the commercializing stage not something all biopharmaceutical companies could say a few weeks ago the company announced that it had entered into an agreement with medicare and medicaid to participate in a national drug rebate program or or ndrp for its substance vexy now sandra pelleter which is the ceo of evofam stated that the contraceptive choice should not be a luxury available to only some women we are proud to participate in the ndrp ensuring that millions of women across the nation who rely on medicare for health care coverage have access to fexi so let's take a look right here ticker symbol evfm this stock was up about less than a percent on friday at the close currently trading at 2.83 cents per share if we take a look at the one-year chart this stock has been down here at this new support level that it created around this two dollar level and it's been bouncing there for about two or three months now we see volume is you know steadily around that two million shares per day a little bit less a little bit higher when we finally saw this uh jump from two dollars all the way up here to about 2.58 cents and now in the past week we've seen this wedge created and the stock is continuing this run up so if we look at the one month chart this stock is on a you know of a little bit of a trend on up in the past month so if we take a look here it's you know continuously going up so we're creating this little bit of a wedge so in the past six months you can see that this stock is finally you know trying to break out of this area that it was trading at before and it's trying to break through if it does that it can go to this next resistance level at around the 3.50 level so we have about 70 cents before we hit that resistance level if it hits that resistance level good volume if it it can definitely break through that is our resistance then we have all the way up to a gap of about five dollars before we hit the next resistance level so this is definitely one to keep an eye out on to see if we can break through that three dollar fifty cents level and then the five dollar level after that so we definitely need some more positive news and more volume on this one but definitely one to keep on your list coming in at the number four spot for our biotech picks is going to be a damas pharmaceutical corp while dama's pharmaceutical stock was down about 11 during midday trading its after-hour gains on january 21st were very very strong after the market closed adm p stock gained around 52 in value and this was on friday morning bringing his shares to priced around 127 cents and it continued that run the gains comes as the company announced the submission of an investigational new drug application to the fda this application pertains to it's a temporal ind substance which could be used in treatment and preventing the rona now the drug serves to target the acute respiratory distress system or ards in more advanced cases of the rona virus this happens to be one of the leading causes of death from the virus as well in recent studies temephil showed efficacy in lowering platelet aggregation and dropping restive oxygen species levels in order to treat the rona drugs need to target both hypoxia and symptoms known as the cytokine storm if it is able to do both of these successfully it could be a major winner in the fight against the ronavirus additionally this drug could be used in a wide variety of other respiratory illnesses outside of the ronavirus over the past 12 months shares of admp stocks have shot up around 200 percent including this week's gain one thing to keep in mind is that the gains like this are quite unsustainable and can often be driven purely by speculation by the damascus pharmaceutical does look like it's working on becoming a large part of the warner virus industry with that considered is admp on your list of penny stocks to watch well let's take a look at the charts so like we just said admp is the ticker symbol the stock was up about 41 on friday at the close so it had a major gain after that you know announcement that it had currently trading at 1.79 cents per share so this one was on fire i mean it broke through that previous resistance area that was around 1.45 cents we definitely destroyed that so this stock had a support here around the 41 cents level and we can see that you know since january the stock went from 49 cents to about a dollar 79 cents so we saw about a 200 percent gain just right there in a matter of a few weeks you know it can continue to gain this momentum shares started to trade around 20 million shares every single day we even had 84 million shares at one day and even 277 million shares previous week so this one jumped from that 50 cent level all the way up here to about 80 cents then we saw that huge news that came out last week and boom the stock jumped up about another dollar so you know the stock is on fire right now we're going to be looking forward to this week is for this one to continue its run up we might see a little bit of a pullback and then hopefully another bounce on up to make even higher highs for the 52-week high so this is some positive news and that is something that drives up these penny stocks now always this doesn't mean always that these penny stocks are going to you know push up with positive news or just news in general sometimes we have the sell the news type situation where penny stocks tend to sell off after these type of news but this one definitely is a runner after this news and we might see a little bit of a pullback but then we might see another jump so that this one is definitely one to keep it on your radar for the next couple of days as it could continue its push on up last but not least coming in the number five penny stock is gonna be neos therapeutics this is gonna be our fifth biotech penny stock on our list neos therapeutics has been on the move since the start of the fourth quarter last year this year has been relatively quiet on the news front so far however neo's president and ceo jerry mclaughlin did present last week at the hc wainwright bioconnect conference one of the driving points of the speculation has been concerning a pending merger deal with a2 bioscience last month the two signed a definite agreement whereby neos will merge with with a wholly owned subsidiary of ike2 in an all stock transaction it's truly transformative in transaction elevating the newly combined company to a 100 million revenue the combination of nios and i2 business further increases our footprint in an attractive pediatric medicine market following our acquisition of the circu pediatric rx assets last year this transaction is an excellent strategic fit with our market expansion plan and we believe creates strong stockhold value this is what the ceo of a2 bioscience said right now this merger is set to close by the second quarter of this year in 2021 so ticker symbol n-e-o-s it was up about two percent on friday at the close and currently the stock is stringing at around 84 cents per share so it's you know a little bit less under than a dollar if we take a look here you know we have this is pretty much where the support level is around this 70 80 cents level then we broke down and created a new support around this 50 cents level but we're breaking through after this you know news and all this going on with it in this year so far it's went up about 20 cents or about you know 30 so far this year and we see you know it continues to go now what we're going to be looking forward to with this one is for it to break through this first resistance at around one dollar if it can break through that first resistance then we have a second resistance up here around 1.25 cents once that resistance gets broken we continue to push all the way into about a dollar and a half or a dollar and seventy five cents so we have you know two or three resistance levels to look forward to in the next few weeks in the next few months even potentially a year depends you know how long it takes and if at all it even pushes up but this is just potential and hypothetical what we're looking forward to obviously we need more volume we're only trading around 4 million shares 2 million shares we had you know 6 million shares and even 33 million shares on the news right there when they announced the merger so we're going to be looking for more you know news to pop out more of this volume to pick up and hopefully break through this 1.25 cents resistance if it can break through that we can definitely see another run up after that so that's what we're going to be looking out for as always guys i hope you guys enjoyed the five biotech penny stocks on our list and this is not financial advice this is just for educational purposes so before investing into any type of stocks make sure you speak to your financial advisor i am not a financial advisor i am just looking at this so make sure you do your own due diligence before investing into any type of stocks do not trade stocks based off of somebody else's opinion only trade if you are sure about it if you guys want to sign up for weeble robin who are m15 and finance you can check the links in the description get your four free stocks when you sign up with weeble today and as always smash that like button subscribe to the channel leave a comment below what penny stocks you're trading right now and i hope you guys enjoyed and i hope to see you guys next time goodbye